Sorrento Gets Green Light To Delay $21M Ch. 11 Sale
By Clara Geoghegan · March 26, 2024, 7:45 PM EDT
Drug developer Sorrento Therapeutics can push the close of its $20.9 million asset sale from Thursday to April 1, a Texas bankruptcy judge ruled Tuesday, after attorneys for the debtor said...
To view the full article, register now.
Try a seven day FREE Trial
Already a subscriber? Click here to login